- Saudi Arabia
- /
- Chemicals
- /
- SASE:2210
Nama Chemicals' (TADAWUL:2210) Solid Earnings May Rest On Weak Foundations
Nama Chemicals Company's (TADAWUL:2210) healthy profit numbers didn't contain any surprises for investors. However the statutory profit number doesn't tell the whole story, and we have found some factors which might be of concern to shareholders.
The Impact Of Unusual Items On Profit
To properly understand Nama Chemicals' profit results, we need to consider the ر.س308m gain attributed to unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. We can see that Nama Chemicals' positive unusual items were quite significant relative to its profit in the year to September 2025. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.
Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Nama Chemicals.
Our Take On Nama Chemicals' Profit Performance
As previously mentioned, Nama Chemicals' large boost from unusual items won't be there indefinitely, so its statutory earnings are probably a poor guide to its underlying profitability. As a result, we think it may well be the case that Nama Chemicals' underlying earnings power is lower than its statutory profit. On the bright side, the company showed enough improvement to book a profit this year, after losing money last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Case in point: We've spotted 2 warning signs for Nama Chemicals you should be mindful of and 1 of them can't be ignored.
Today we've zoomed in on a single data point to better understand the nature of Nama Chemicals' profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
Valuation is complex, but we're here to simplify it.
Discover if Nama Chemicals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SASE:2210
Nama Chemicals
Owns, operates, and manages industrial projects in the petrochemical and chemical sectors in Saudi Arabia, the Gulf countries, Asia, Africa, Europe, and other territories.
Slight risk and slightly overvalued.
Market Insights
Weekly Picks

When GPS fails: this small cap is fixing a $54B drone problem

Why Amdocs is a high conviction Buy for me?
Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend
Recently Updated Narratives

302 Million Oz Silver Project in Mexico: Low Cost Underground Giant Ready to Explode

7/8/26 — Oscar Health: Trading 95.4% below Fair Value with +2070.2% Upside Potential

Procter & Gamble - A Fundamental Valuation
Popular Narratives

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
A wonderful business at reasonable price.
Amazon's high growth, high tech segments propel its profits, while traditional segments plod along
Trending Discussion


